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Abstract
Background: Diabetes has become a global health emergency affecting high-, middle- and low-income countries.
Previous systematic reviews have either focused on patients’ adherence to diabetes self-care behaviours only or
barriers to diabetes care (including self-care) only in the published literature and have not also analysed data
separately for low- and middle-income countries (LMICs). Thus, none have focused on adherence with, and barriers
to, self-care behaviours from the perspectives of both patient and providers in low- and middle-income countries
(LMICs). This systematic review will evaluate the published literature on adherence to five diabetes self-care
behaviours (i.e., diet, exercise, self-monitoring of blood glucose, medication taking and foot care) and associated
barriers in type 2 diabetes patients in LMICs. Healthcare providers’ barriers to the provision of diabetes self-care
support will also be reviewed.
Methods: This narrative review will be reported in accordance with the guidelines of the Preferred Reporting Items
for Systematic review and Meta-Analysis Protocols (PRISMA-P). The electronic databases, MEDLINE, EMBASE, CINAHL,
SCOPUS, PsycINFO, Cochrane Library and the British Nursing Index will be searched. Qualitative and quantitative
studies reporting on type 2 diabetes patients’ adherence to self-care behaviours and associated barriers in LMICs
will be included. Studies also reporting on barriers encountered by providers in LMICs providing diabetes care and
supporting patients to adhere to self-care behaviours will also be included. Cross-sectional studies, observational
cohort studies, baseline data of randomised controlled trials and qualitative studies will be eligible. Two
independent reviewers will screen articles for inclusion, undertake quality assessment of included studies and
execute data extraction using standardised forms. Discrepancies will be discussed to reach consensus, and another
reviewer will adjudicate if the need arises. The Guidance of Narrative Synthesis in Systematic Reviews will be
employed to explore relationships within and between included studies.
Discussion: This review will provide evidence on adherence to self-care behaviours by type 2 diabetes patients in
LMICs. Barriers experienced by patients in LMICs to adhere to recommended self-care behaviours will also be
identified. Barriers experienced by healthcare providers in LMICs in providing self-care support patients will also be
determined.
Systematic review registration: PROSPERO CRD42016035406
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Background
Diabetes affected 422 million adults in 2014 compared to
108 million in 1980 [1]. The increasing prevalence is asso-
ciated with an increase in the prevalence of risk factors
such as excess body weight, sedentary lifestyle, diet and
ageing populations [2, 3]. In the last 10 years, the preva-
lence of diabetes has risen faster in low- and middle-
income countries than in high-income countries [1]. The
World Health Organization (WHO) anticipates that infec-
tious diseases, maternal and infant mortality and malnu-
trition will be overtaken by non-communicable diseases
such as diabetes mellitus (DM) in low- and middle-
income countries (LMICs) by 2030 [4, 5]. Characterised
by hyperglycaemia, insulin resistance and relative insulin
deficiency, type 2 DM is the most frequently occurring
form of DM globally [6–8].
Diabetes patients of LMICs are at increased risk of late
diagnosis, poor diabetes control, hospitalisations and the
development of diabetes-related complications [9, 10].
Also a higher proportion of premature deaths due to
high blood glucose occurred in LMICs than in high-
income countries [1].
Being a complex chronic disorder, diabetes care re-
quires regular attention to diet, physical activity, moni-
toring of blood sugar, medications and foot care to
attain positive health outcomes [11]. As has been advo-
cated by clinical practice guidelines from the USA, UK
and globally [12–15], these activities are referred to as
diabetes self-care behaviours requiring the active partici-
pation of the patient in his or her care [15]. As each of
these behaviours is important to health outcomes, it is
essential to have a clear understanding of the level of ad-
herence to each self-care behaviour and barriers to the
performance of each of them for LMICs.
A number of reviews have examined adherence to self-
care behaviours among type 2 diabetes patients [15] and
barriers to diabetes care [16–18] including self-care [19].
The review by Coyle et al. included studies from low-
and middle-income countries (LMICs) but only evalu-
ated patients’ adherence to self-care behaviours (i.e. did
not report on patients’ barriers to self-care) and did not
analyse data from LMICs separately. The reviews by Pun
et al. and Nam et al. [16–18] also included studies from
LMICs, examined patient and provider barriers to gen-
eral diabetes care including self-care but did not con-
sider barriers to self-care behaviours separately and did
not analyse LMICs data separately. Also, they did not
undertake quality assessment of the included studies.
The review by Sohal et al. evaluated patient and provider
barriers and facilitators to diabetes management using
only studies conducted in South Asia [18]. Wilkinson et
al. [19] reviewed the literature to identify factors that in-
fluence patients’ ability to self-care for their diabetes, but
only included qualitative studies, considered both type 1
and type 2 diabetes patients, did not include studies
among providers and did not analyse LMICs data separ-
ately. Accordingly, a systematic review of the published
literature from LMICs on patient adherence with, and
the barriers to, self-care behaviours from the perspec-
tives of both the patient and providers is warranted.
This systematic review will examine both qualitative
and quantitative studies conducted in LMICs related to:
a. Type 2 diabetes patients’ adherence to five self-care
behaviours: recommended diet, sufficient exercise,
diabetes medications, self-monitoring of blood glu-
cose and foot care.
b. Barriers to self-care behaviours among patients with
type 2 diabetes
c. Barriers to the provision of appropriate care to
patients with type 2 diabetes among healthcare
providers.
Methods
This systematic review will be reported in accordance
with the guidelines of the Preferred Reporting Items for
Systematic review and Meta-Analysis Protocols
(PRISMA-P) 2015 [20]. Details of this can be found in
an additional file (see Additional file 1).
Definition of low- and middle-income countries
Based on the 2015 Gross National Income per capita
(GNI), low-income countries are those with a GNI per
capita of ≤US$1,045 and middle-income countries are
those with a GNI per capita of >US$1,045 but
<US$12,736 [21]. Any country listed by World Bank as a
LMIC at any point during the review period will be
included.
Information sources
Electronic databases including MEDLINE (OVID inter-
face, 1948 and beyond), EMBASE (OVID interface, 1980
onwards), CINAHL, SCOPUS, PsycINFO, Cochrane
Library and the British Nursing Index will be searched.
The websites of relevant organisations such as the Inter-
national Diabetes Federation (IDF), WHO and other
diabetes-related institutions will also be examined for
other potentially relevant studies. To ensure relevant
publications are captured, the reference lists of relevant
studies or systematic reviews will be hand searched.
Search strategy
The databases will be searched using medical subject
headings (MeSH) and free text words relating to the
themes of this review (Table 1). Truncation and appro-
priate Boolean operators will be incorporated into the
search strategy to cater for the different use of terms.
Limitations pertaining to the inclusion and exclusion
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criteria will be set. An Ovid MEDLINE strategy will be
developed by VM and other members of the research
team under the guidance of a librarian with experience
in systematic review searching. The finalized Ovid MED-
LINE strategy will be adapted to the syntax and subject
headings of the other databases. The search strategy will
be reviewed by another librarian in accordance with the
Peer Review of Electronic Search Strategies (PRESS)
checklist. The execution of the search strategy will be
done by VM.
Eligibility criteria
Studies will be included in accordance with the criteria
outlined below.
a. Type of data: Studies using quantitative, qualitative
or both approach(es) will be included. Included
studies will be limited to published papers including
published theses/dissertations.
b. Study design: Cross-sectional studies, cohort studies,
baseline data from randomised controlled trials
(RCTs) and qualitative studies (e.g. in depth inter-
views, focus groups) will be eligible for inclusion.
c. Study participants: (i) Adults with type 2 diabetes
from LMICs. Studies where the majority (≥50%) of
participants are from a LMIC will be included. (ii)
Studies that report on the barriers faced by
healthcare professionals who deliver care to type 2
diabetes patients in LMICs will also be eligible for
inclusion.
d. Search limitations: All studies published from
January 1990 onwards will be included. This time
frame is informed by global estimates of diabetes that
recognised diabetes as a global disease affecting adult
populations of developing countries or LMICs [22].
e. Study focus: Studies that are concerned with patient
adherence to self-care behaviours and barriers to
self-care. Also, studies that report on barriers experi-
enced by providers to support patients to self-care
for their diabetes will be included.
f. Setting: Both population- and clinic-based studies
will be eligible for inclusion.
g. Language: Due to funding constraints, only studies
published in English will be eligible for inclusion
Exclusion criteria
Studies will be excluded if the majority of participants
were younger than 18 years or had gestational diabetes.
Conference proceedings, non-peer reviewed papers,
opinion pieces, commentaries, case reports, abstracts
and systematic reviews will be excluded.
Data management, screening and selection
All search results will be downloaded into the reference
manager ENDNOTE version X7 for screening. The lib-
eral accelerated screening method for the screening of
the literature search results will be adopted [23]. Firstly,
VM will screen the title, abstract and subject headings of
the citations in accordance with the eligibility criteria.
Those that meet the eligibility criteria will be included
and moved into the next level of assessment as well as
Table 1 Search strategy
Searches
1 diabetes mellitus.mp. or Diabetes Mellitus/
2 Diabetes Mellitus, Type 2/or Diabetes Mellitus, or diabetes
mellitus type 2.mp.
3 (non insulin*dep* or noninsulin*dep*).mp. [mp = title,
abstract, original title, name of substance word, subject
heading word, keyword heading word, protocol
supplementary concept word, rare disease supplementary
concept word, unique identifier]
4 1 or 2 or 3
5 self-care.mp. or Self Care/
6 self-manage*.mp. or Patient Education as Topic/
7 self-care behaviours.mp.
8 5 or 6 or 7
9 diet.mp. or Diet/
10 Food Habits/or dietary habit*.mp.
11 nutrition.mp.
12 9 or 10 or 11
13 exercise.mp. or Exercise/
14 physical activity.mp.
15 13 or 14
16 Blood Glucose Self-Monitoring/
17 Self Care/or blood glucose testing.mp.
18 16 or 17
19 Self Care/or foot care.mp.
20 Patient Compliance/or medication taking.mp. or Self
Administration/or Medication Adherence/
21 adherence.mp.
22 20 or 21
23 barrier.mp.
24 Health Services Accessibility/or Health Personnel/or patient
barrier.mp. or “Attitude of Health Personnel”/
25 23 or 24
26 Developing Countries/or Socioeconomic Factors/or Low-
income countries.mp.
27 Developing Countries/or middle-income countries.mp.
28 26 or 27
29 4 or 8 or 12 or 15 or 18 or 19 or 22 or 28
30 25 and 29
31 limit to (english language and yr = “1990 -Current” and “all
adult (19 plus years)”)
*Represents Truncation
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those that were unclear. Those that are excluded as per
the eligibility criteria will be reviewed by another mem-
ber of the review team to confirm exclusion or other-
wise. Secondly, full-text screening will be carried out by
two members of the review team independently. Discus-
sions and consensus building between the two reviewers
will be used to resolve discordance and one or two arbi-
trators will adjudicate unresolved disagreements. In ac-
cordance with the PRISMA flow diagram, the entire
selection process and reasons for exclusion will be re-
corded [24, 25]. Questions for screening will be devel-
oped in accordance with the eligibility criteria for the
two-stage assessment of potentially eligible studies. The
screening questions will be piloted, prior to the formal
screening processes.
Characteristics of included studies
The content of each included study will be extracted by
two independent reviewers and recorded on a standard
data collection form utilised in other reviews [24]. The
following data will be extracted:
a. Publication details: author(s) names, year of
publication, country of study and years data were
collected
b. Study setting: population based, clinic-based
c. Study design: cross-sectional, cohort, baseline data
from RCT, qualitative (focus groups, in-depth
interviews)
d. Details of study population: demographics, sample
size, eligibility criteria
e. Sampling methods: consent rates
f. Measures
g. Results
During the data extraction process, disagreements will
be resolved through discussion and consensus building
and one or two arbitrators will adjudicate if needed.
Quality assessment
All quantitative studies will be assessed using the
National Heart, Lung and Blood Institute (NHLBI) stan-
dardised quality rating tools for quality assessment [26].
The NHLBI standardised tools are study-design specific
[26, 27]. Studies having observational cohort and cross-
sectional designs will be assessed using the NHLBI stan-
dardized Quality Assessment Tool for Observational
Cohort and Cross-sectional studies. Data only from the
baseline phase of RCTs will be included in this review
because adherence to self-care behaviours and reporting
of barriers may change at follow-up as a result of an
intervention. Baseline data only from an RCT represents
a cross-sectional assessment and therefore the NHLBI
standardized Quality Assessment Tool for Observational
Cohort and Cross-sectional studies will also be used for
such studies.
The NLBI tools will allow for assessment of potential
flaws in study methods including sources of bias, sam-
pling, confounding, study power and other relevant fac-
tors. Each study will be judged as “good”, “fair” or “poor”
quality based on ratings of a list of items included in the
tools. Globally, a good study has the least risk of bias
and is considered valid. A fair study is prone to some
bias but insufficient to invalidate its findings, varying in
its strengths and weaknesses. A poor study has high risk
of bias and is considered invalid. Quality assessment will
be conducted independently by two members of the re-
view team. Differences will be resolved through discus-
sions between these two and if unresolved the other
members of the team will be consulted for adjudication.
Qualitative studies will be assessed according to quality
assessment categories adopted by Popay, Rogers and
Williams [28]. These categories will pertain to relevance
and appropriateness of research design, study context, use
of convenience/purposive sampling, richness of data, thor-
oughness of data analysis and clarity of interpretation and
logical generalisation of findings based on theoretical
underpinnings. This tool has been used widely for asses-
sing the quality of qualitative studies in several systematic
reviews [29–31]. It has been reported to be applicable
across a wide range of qualitative methods [30, 32].
Data analysis and synthesis
A systematic narrative synthesis will be conducted.
Tables and narrative summaries will be used to present
the characteristics and findings of included studies. Rela-
tionships within and between included studies will be
explored as well as assessment of the robustness of the
synthesis, in accordance with the Guidance of Narrative
Synthesis in Systematic reviews produced by the Eco-
nomic and Social Research Council (ESRC) methods
programme [33]. This guidance provides a framework
for the execution of narrative synthesis using both broad
and specific techniques and tools. It has been used
widely in several systematic reviews [34–38]. VM will
conduct the synthesis in consultation with the rest of
the review team members.
Discussion
Systematically reviewing the published literature from
LMICs will increase knowledge on the self-care behav-
iours that are commonly adhered to and those that are
not among type 2 diabetes patients in LMICs. It will also
provide data relating to barriers faced by patients to self-
care for their diabetes and providers to support patients
to self-care in LMICs which will assist with the design of
interventions to improve care planning and delivery in
this population. The inclusion of both qualitative and
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quantitative studies will allow for a comprehensive re-
view of the published literature.
Additional files
Additional file 1: PRISMA-P checklist. This checklist provides a list of
recommended items to include in a systematic review protocol and the
pages upon which those items are covered in the protocol. (DOCX 30 kb)
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